178 related articles for article (PubMed ID: 22687418)
41. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
[TBL] [Abstract][Full Text] [Related]
42. Anti-Influenza Activity of an Ethyl Acetate Fraction of a
Kim YS; Li W; Kim JH; Chung HS; Choi JG
Oxid Med Cell Longev; 2020; 2020():8824934. PubMed ID: 33204399
[TBL] [Abstract][Full Text] [Related]
43. Novel oral anti-influenza drug candidate AV5080.
Ivachtchenko AV; Ivanenkov YA; Mitkin OD; Yamanushkin PM; Bichko VV; Shevkun NA; Karapetian RN; Leneva IA; Borisova OV; Veselov MS
J Antimicrob Chemother; 2014 Jul; 69(7):1892-902. PubMed ID: 24729605
[TBL] [Abstract][Full Text] [Related]
44. Anti-influenza virus activity of tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone.
Yazawa K; Kurokawa M; Obuchi M; Li Y; Yamada R; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
Antivir Chem Chemother; 2011 Aug; 22(1):1-11. PubMed ID: 21860068
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
[TBL] [Abstract][Full Text] [Related]
46. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
[TBL] [Abstract][Full Text] [Related]
47. Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth.
Kiyohara H; Ichino C; Kawamura Y; Nagai T; Sato N; Yamada H
J Nat Med; 2012 Jan; 66(1):55-61. PubMed ID: 21671149
[TBL] [Abstract][Full Text] [Related]
48. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
49. Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens.
Lee HJ; Lee YN; Youn HN; Lee DH; Kwak JH; Seong BL; Lee JB; Park SY; Choi IS; Song CS
Poult Sci; 2012 Jan; 91(1):66-73. PubMed ID: 22184430
[TBL] [Abstract][Full Text] [Related]
50. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.
Yamada K; Ogawa H; Hara A; Yoshida Y; Yonezawa Y; Karibe K; Nghia VB; Yoshimura H; Yamamoto Y; Yamada M; Nakamura K; Imai K
Antiviral Res; 2009 Jul; 83(1):35-44. PubMed ID: 19501255
[TBL] [Abstract][Full Text] [Related]
51. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
Abed Y; Baz M; Boivin G
Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
[TBL] [Abstract][Full Text] [Related]
52. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
[TBL] [Abstract][Full Text] [Related]
53. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
Leneva IA; Goloubeva O; Fenton RJ; Tisdale M; Webster RG
Antimicrob Agents Chemother; 2001 Apr; 45(4):1216-24. PubMed ID: 11257037
[TBL] [Abstract][Full Text] [Related]
56. Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.
Das A; Adak AK; Ponnapalli K; Lin CH; Hsu KC; Yang JM; Hsu TA; Lin CC
Eur J Med Chem; 2016 Nov; 123():397-406. PubMed ID: 27487569
[TBL] [Abstract][Full Text] [Related]
57. Structural basis for a class of nanomolar influenza A neuraminidase inhibitors.
Kerry PS; Mohan S; Russell RJ; Bance N; Niikura M; Pinto BM
Sci Rep; 2013 Oct; 3():2871. PubMed ID: 24129600
[TBL] [Abstract][Full Text] [Related]
58. Anti-influenza virus effect of aqueous extracts from dandelion.
He W; Han H; Wang W; Gao B
Virol J; 2011 Dec; 8():538. PubMed ID: 22168277
[TBL] [Abstract][Full Text] [Related]
59. Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs.
Jin J; Chen S; Wang D; Chen Y; Wang Y; Guo M; Zhou C; Dou J
Biomed Pharmacother; 2018 Jan; 97():385-394. PubMed ID: 29091888
[TBL] [Abstract][Full Text] [Related]
60. Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1N1 viruses: its role in viral hemagglutination and neuraminidase inhibition.
Sriwilaijaroen N; Fukumoto S; Kumagai K; Hiramatsu H; Odagiri T; Tashiro M; Suzuki Y
Antiviral Res; 2012 May; 94(2):139-46. PubMed ID: 22453134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
